KERTYOL PSO Daily balm
Complementary care for psoriasis-prone skin

KALYPSO product
Status
Status :
Completed
Type of study
Post-marketing study
Min. Age
18
Years old
Max. Age
83
Years old
Gender
All

Brief summary

The objectives of this study were to evaluate the effectiveness and tolerance of KERTYOL PSO daily balm on itching* in psoriasis-prone skin, in combination with medicinal treatments.

The subjects' skin was evaluated during 2 dermatological consultations spaced 12 weeks apart.

* Linked to dry skin

Area of application :
Dermatology
Target :
Skin prone to couperosis
Dermo-cosmetic product :
KERTYOL PSO Daily balm
Brand :
Ducray
Start Date :
22 May 2021
End Date :
21 July 2022
Number of subjects :

463

Countries :
Belgium
Czech Republic
France
Greece
Italy
Slovakia
Spain
Study ID : NA